Persistence and clearance of high‐risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study-Reference-Cited by-同舟云学术

Persistence and clearance of high‐risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study

Published:2021-06-14 Issue:12 Volume:128 Page:1986-1996
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Luckett R¹²,Painter H²,Hacker MR¹³,Simon B²,Seiphetlheng A⁴,Erlinger A¹,Eakin C²⁵,Moyo S²³,Kyokunda LT⁶,Esselen K¹⁷,Feldman S⁷⁸,Morroni C²⁹,Ramogola‐Masire D¹⁰

Affiliation:

1. Department of Obstetrics and Gynecology Beth Israel Deaconess Medical Center Boston MA USA

2. Botswana Harvard AIDS Institute Partnership Gaborone Botswana

3. Harvard T.H. Chan School of Public Health Boston MA USA

4. Department of Obstetrics and Gynaecology Princess Marina Hospital Gaborone Botswana

5. Department of Obstetrics and Gynecology Creighton University School of Medicine‐Phoenix Phoenix AZ USA

6. Department of Pathology University of Botswana Gaborone Botswana

7. Harvard Medical School Boston MA USA

8. Brigham and Women’s Hospital Boston MA USA

9. Department of International Public Health Liverpool School of Tropical Medicine Liverpool UK

10. Department of Obstetrics and Gynaecology University of Botswana Gaborone Botswana

Funder

Harvard Catalyst

Beth Israel Deaconess Medical Center

Harvard University Center for AIDS Research

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.16758

Reference45 articles.

1. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

2. Cervical Cancer Prevention in Low- and Middle-Income Countries: Feasible, Affordable, Essential

3. Recommendations for Cervical Cancer Prevention in Sub-Saharan Africa

4. U.S. Preventive Services Task Force.Final recommendation statement cervical cancer screening[www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementFinal/cervical‐cancer‐screening]. Accessed 29 September 2020.

5. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Ureaplasma urealyticum and Ureaplasma parvum as Risk Factors for Cervical Dysplasia with Human Papillomavirus;Journal of Pure and Applied Microbiology;2023-09-01

2. Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation;Infectious Agents and Cancer;2023-05-10

3. Tracking HPV Infection, Associated Cancer Development, and Recent Treatment Efforts—A Comprehensive Review;Vaccines;2023-01-01

4. Vaginal microbiota and HPV clearance: A longitudinal study;Frontiers in Oncology;2022-10-24

5. Factors associated with persistence and clearance of HPV16/18 among rural Chinese women: a cohort study in Wufeng, Hubei province;Women & Health;2022-04-08